Two-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: A prospective study

Journal of Clinical Psychiatry

Volumn 71, Issue 12, 2010, Pages 1590-1597

  Bejerot, Susanne ^a   Rydén, Eleonore M ^a   Arlinde, Christina M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DEXAMPHETAMINE; ESCITALOPRAM; HYPNOTIC AGENT; METHYLPHENIDATE; MOOD STABILIZER; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; OLANZAPINE; SEROTONIN UPTAKE INHIBITOR;

ABDOMINAL PAIN; ADULT; ADULT DISEASE; ANXIETY DISORDER; APPETITE; ARTICLE; ASTROCYTOSIS; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; COMORBIDITY; CONSTIPATION; DEPRESSION; DIARRHEA; DISTRACTIBILITY; DIZZINESS; DROWSINESS; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLOW UP; HALLUCINATION; HEART RATE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; INCONTINENCE; INSOMNIA; IRRITABILITY; LIBIDO; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; MUSCLE TONE; MYALGIA; NAUSEA; NERVOUSNESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTLESSNESS; SEIZURE; SIDE EFFECT; SLEEP DISORDER; SOCIAL PHOBIA; TACHYCARDIA; TIC; TREATMENT DURATION; TREATMENT OUTCOME; TREMOR; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

ADULT; ANXIETY; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; IMPULSIVE BEHAVIOR; IRRITABLE MOOD; MALE; OUTPATIENTS; PROSPECTIVE STUDIES; PSYCHOMOTOR AGITATION; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 78650549641     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05168pur     Document Type: Article

References (23)

1. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190(5):402-409.
2. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816-818.
3. Larsson H, Lichtenstein P, Larsson JO. Genetic contributions to the development of ADHD subtypes from childhood to adolescence. J Am Acad Child Adolesc Psychiatry. 2006;45(8):973-981.
4. Davidson MA. ADHD in adults: a review of the literature. J Atten Disord. 2008;11(6):628-641.
5. Rydén E, Bejerot S. Autism spectrum disorder in an adult psychiatric population: a naturalistic cross sectional controlled study. Clinical Neuropsychiatry. 2008;5:13-21.
6. Mancebo MC, Garcia AM, Pinto A, et al. Juvenile-onset OCD: clinical features in children, adolescents and adults. Acta Psychiatr Scand. 2008;118(2):149-159.
7. Weisler RH, Biederman J, Spencer TJ, et al. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006;11(8):625-639.
8. Biederman J, Mick E, Surman C, et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;59(9):829-835.
9. Friedman R. Adults benefit from drug treatment for ADHD. Medscape Medical News. http://www.medscape.com/viewarticle/456007. May 21, 2003. Accessed February 24, 2009.
10. Spencer T (speaker). Preliminary Results of a Six-Month Trial of Methylphenidate in Adults With ADHD (cassette recording no. 03APA-S54B). Valencia, CA: Mobiltone Company, Inc; 2003.
11. Weiss M, Hechtman L; Adult ADHD Research Group. A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry. 2006;67(4):611-619.
12. Charach A, Figueroa M, Chen S, et al. Stimulant treatment over 5 years: effects on growth. J Am Acad Child Adolesc Psychiatry. 2006;45(4):415-421.
13. Miller AR, Lalonde CE, McGrail KM. Children's persistence with methylphenidate therapy: a population-based study. Can J Psychiatry. 2004;49(11):761-768.
14. Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40(8):922-928.
15. Aanonsen NO, Lensing MB, Prietz R, et al. De sakkyndig team for hyperkinetisk forstyrrelse/ADHD for helseregionene sør og øst. Rapport til Statens helsetilsyn. Utprøvende behandling med sentralstimulerende legemidler till voksne med hyperkinetisk förstyrrelse/ADHD [The expert team for the hyper-kinetic disorder/ADHD for health regions South and East. Testing treatment with stimulant drugs to adults with hyper-kinetic disorder/ADHD. Report to the Norwegian Board of Health Supervision]. Avd. For voksenhabilitering. Oslo, Norway: Ullevall University hospital; 2005.
16. Biederman J, Spencer TJ, Wilens TE, et al. SLI381.304 study group. Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr. 2005;10(suppl 20):16-25. (Pubitemid 43010494)
17. Kadesjö B, Janols LO, Korkman M, et al. The FTF (Five to Fifteen): the development of a parent questionnaire for the assessment of ADHD and comorbid conditions. Eur Child Adolesc Psychiatry. 2004;13(suppl 3):3-13.
18. Wender PH. Attention-Deficit Hyperactivity Disorder in Adults. Oxford, England: Oxford University Press; 1995:252-253.
19. Reimherr FW, Marchant BK, Strong RE, et al. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry. 2005;58(2):125-131.
20. Reimherr FW, Williams ED, Strong RE, et al. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry. 2007;68(1):93-101.
21. Gillberg C, Rasmussen P. Perceptual, motor and attentional deficits in six-year-old children: screening procedure in pre-school. Acta Paediatr Scand. 1982;71(1):121-129. (Pubitemid 12210267)
22. Robison RJ, Reimherr FW, Marchant BK, et al. Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis. J Clin Psychiatry. 2008;69(2):213-221.
23. Stahlberg O, Soderstrom H, Rastam M, et al. Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders. J Neural Transm. 2004;111(7):891-902.